• Dr. Roach is a Professor of Radiation Oncology and Urology at the University of California San Francisco. He is recognized as an authority on the treatment of localized prostate cancer with extensive publications on the subject. Dr. Roach was a leader in establishing the American College of Radiology (ACR) Appropriateness Criteria Guidelines for prostate cancer from 1996 through 2006. He has served on numerous editorial boards and was appointed (2013) by President Obama to serve on a 6-year term on the National Cancer Advisory Board, involved in defining the research agenda for the United States.

  • Dr. Spratt is the Chairman and Professor of Radiation Oncology at University Hospitals Seidman Cancer Center and Case Western Reserve University. He is an international expert in the management of prostate cancer and the development and validation of prognostic and predictive biomarkers. He serves as the Chair for NRG Oncology's Intact Prostate Cancer Subcommittee, and for the National Cancer Institute's Genitourinary Steering Committee. He is the PI of numerous national and international randomized clinical trials in prostate and bladder cancer.

  • Dr. Richstone is the Chairman of Urology at Northwell Health Lenox Hill Hospital and an internationally renowned pioneer in multiport and single incision robotic surgery. His vast experience – spanning over 20 years and thousands of cases – is matched by the warmth of his personality and his commitment to quality.

  • Donald B. Fuller, M.D. earned his doctorate at the University of Washington School of Medicine in Seattle, Washington. He completed his internship at Santa Barbara Cottage Hospital in Santa Barbara, California and his Radiation Oncology residency at LDS Hospital in Salt Lake City, Utah, subsequently receiving advanced training in prostate brachytherapy and CyberKnife stereoctatic radiotherapy techniques. He is certified by the American Board of Radiology in Radiation Oncology.

  • As a Senior Manager at Accuray, Karen leads the user community and engagement team, ensuring the delivery of high-quality radiation therapy solutions to patients worldwide. With over 20 years of experience in the field of radiotherapy, she possesses a deep understanding of the clinical and technical aspects of radiation oncology. Karen is also pursuing a PhD at Ulster University, conducting research on the impact of advanced clinical practices with a specific focus on non-medical prescribing. The aim of this research is to advance the role of therapeutic radiographers and enhance patient outcomes. Passionate about sharing knowledge and expertise, Karen has published several papers on radiation therapy and oncology.

  • Dr. Zelefsky is Vice Chair and the Director of Brachytherapy Services in the Department of Radiation Oncology at NYU Grossman School of Medicine. He serves as the Editor-in-Chief of the journal, Brachytherapy, and has published extensively on the management of prostate cancer. Dr. Zelefsky helped pioneer the use of IMRT, IGRT, SBRT in the treatment of men with prostate cancer and is a seminal voice in managing prostate malignancy.

  • Dr. Blacksburg is the Global Chief Medical Officer of Accuray, Inc. He previously served as the Chair of Radiation Medicine at Lenox Hill Hospital and Associate Professor of Radiation Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.  He was the Associate Director of Radiation Oncology at NYU-Long Island Hospital and the Medical Director of the NYCyberknife Facility. Dr. Blacksburg has an expertise involving the use of SBRT to treat prostate cancer and has lectured and presented a wide body of research on the international stage.  He is an expert in medical informatics and health sector management.

  • Dr. Collins is the Director of the Cyberknife Prostate Program at MedStar Georgetown University Hospital and an Associate Professor of Radiation Medicine at Georgetown University School of Medicine. Dr. Collins has published extensively on outcomes and quality of life as it relates to prostate SBRT and is a frequent international lecturer. He serves as a reviewer and editorial board member for numerous medicine and oncology journals and, has amongst the highest volume of Prostate SBRT manuscripts published to-date. He has been nicknamed “The Oracle” on prostate SBRT Quality of Life.

  • Hina Saeed, M.D., FACRO, is a board-certified radiation oncologist and deputy director of radiation oncology at the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. She specializes in cancer care using advanced radiation oncology methods. Prior to joining Lynn Cancer Institute in 2022, Dr. Saeed worked as an assistant professor of radiation oncology at the Medical College of Wisconsin.

  • Matthew R. Witten, PhD, DABR, is the chief physicist in the Department of Radiation Oncology at NYU Long Island School of Medicine and director of the Division of CyberKnife Radiosurgery, supervising the technical aspects of the radiation therapy program as well as the comprehensive departmental quality assurance program. Dr. Witten leads a team of physicists and dosimetrists who provide the expertise to ensure that patients receive safe and effective radiation therapy treatments across all delivery platforms: linear accelerator, CyberKnife, Radixact, and high-dose-rate brachytherapy modalities.

  • Professor Tome is a Professor of Radiation Oncology and Neurology, as well as the Director of Medical Physics at the Institute for Onco-Physics at the Albert Einstein College of medicine. He is renowned for his impactful work in medicine, particularly in high-precision radiation therapy techniques like photogrammetry, risk adaptive therapy, and hippocampal avoidant cranial radiation to protect neurocognitive functions. He has authored significant texts in medical and mathematical physics, published over 275 articles, co-invented novel Gadolinium-based agents for tumor imaging and therapy, and holds 10 patents.

  • Jordan Johnson is committed to delivering the highest level of cancer care in a patient-centered environment. By providing innovative solutions and education, Jordan helps clients improve productivity, revenue, and both employee and patient satisfaction. Through data-driven strategies, Jordan works to increase efficiency and reduce waste while keeping teams motivated and aligned with the mission to serve patients. Jordan believes that sustaining momentum is a developed skill—essential for success in today’s healthcare landscape. He views true leadership as the ability to influence and sustain that influence, grounded in passion, process, tolerance, and accountability.

  • Alison Tree was appointed as a consultant clinical oncologist at The Royal Marsden in 2014, specialising in radiotherapy and chemotherapy treatment for urological malignancies. Prior to this she spent most of the previous 12 years at The Royal Marsden, training in state of the art chemotherapy and radiotherapy techniques. Her MD thesis was on stereotactic body radiotherapy (SBRT) for prostate and oligometastatic cancer. Her current research interests include technical radiotherapy improvements in prostate cancer, the development of the MR Linac for urological cancers and the use of ablative radiotherapy for oligometastatic disease.

  • Dr. Stock is a Professor of Radiation Oncology at the Icahn School of Medicine at Mount Sinai. An early pioneer of modern prostate brachytherapy, Dr. Stock authored critical publications involving optimal management of prostate malignancy with dose escalated radiation therapy. He has served on the board of American College of Radiology Testing and the American Brachytherapy Society, where he is member at large, and as guest editor of a special Brachytherapy issue of Techniques in Urology.

  • Madhur Garg, MD, MBA, FACR, is the Clinical Director of Radiation Oncology, Director of Montefiore-Einstein’s Proton Therapy Program and Co-Director of Stereotactic Radiation Therapy Program at Montefiore Medical Center. He earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit.

  • Dr. C-M Charlie Ma, PhD, FAAPM, FASTRO, FACMP, FIOP is Professor, Director of Radiation Physics and Vice Chairman of the Department of Radiation Oncology at Fox Chase Cancer Center, Philadelphia, PA. Dr. Ma is specialized in Monte Carlo dose calculation, radiation dosimetry, image guidance, treatment optimization and delivery for intensity-modulated photon therapy, and energy- and intensity-modulated electron and proton beams for radiation therapy. He has edited 4 books and published more than 20 book chapters and 180 peer-reviewed journal articles in these areas.

Course Directors

  • Dr. Haas is Chairman of the Department of Radiation Oncology at NYU-Long Island Hospital and Professor of Radiation Oncology at the NYU Long Island School of Medicine. Dr. Haas was one of the first radiation oncologists to perform prostate SBRT and has amongst the world’s largest clinical experience. He is a reviewer and editor of many preeminent journals and serves as the genitourinary oncology site leader for the Radiosurgery Society.

  • Dr. Lee Goddard is a highly accomplished medical physicist at the Albert Einstein College of Medicine. His extensive publications and presentations focus on advanced radiation therapy techniques, particularly in the realms of stereotactic radiosurgery, stereotactic body radiation therapy, and novel, adaptive radiotherapy treatment approaches. His research has included investigations on enhancing the precision of prostate radiation dose delivery through advanced motion compensation, allowing for reduced PTV margins.

Faculty

REGISTER NOW

Register to book your spot!

REGISTER NOW